INTERNATIONAL PATENT: UNIVERSITE DE BORDEAUX, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX FILES APPLICATION FOR "EX VIVO METHOD FOR PREDICTING THE RESPONSE TO SORAFENIB TREATMENT OF HEPATOCELLULAR CARCINOMA IN A SUBJECT"

GENEVA, Jan. 26 -- UNIVERSITE DE BORDEAUX (35 place Pey Berland33000 Bordeaux), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101 rue de Tolbiac75013 Paris), CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX (12 rue Dubernat33400 Talence) filed a patent application (PCT/EP2025/069344) for "EX VIVO METHOD FOR PREDICTING THE RESPONSE TO SORAFENIB TREATMENT OF HEPATOCELLULAR CARCINOMA IN A SUBJECT" on Jul 08, 2025. With publication no. WO/2026/017471, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SALTEL, Frederic (...